Top

Cardiovascular Intervention and Therapeutics

Published in:

01-04-2017 | Case Report

Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter

Authors: Yoshihide Fujimoto, Norimasa Tonoike, Yoshio Kobayashi

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2017

Abstract

Deployment of polytetrafluoroethylene (PTFE)-covered stent is a useful technique to seal coronary perforation. However, the high profile and low flexibility compromise its deliverability. To facilitate stent delivery, a guide extension catheter (GuideLiner™ catheter) through a 6 Fr guiding catheter has been used. This case report describes a successful deployment of a PTFE-covered stent using a 6 Fr GuideLiner catheter to seal coronary perforation.

Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eiqler NL, et al. Increased coronary perforation in the new device era: incidence, classification, management, and outcome. Circulation. 1994;90:2725–30.CrossRefPubMed

Briguori C, Nishida T, Anzuini A, Di Mario C, Grube E, Colombo A. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation. 2000;102:3028–31.CrossRefPubMed

Gunning MG, Williams IL, Jewitt DE, Shah AM, Wainwright RJ, Thomus MR. Coronary artery perforation during percutaneous intervention: incidence and outcome. Heart. 2002;88:495–8.CrossRefPubMedPubMedCentral

Shirakabe A, Takano H, Nakamura S, Kikuchi A, Sasaki A, Yamamoto E, et al. Coronary perforation during percutaneous coronary intervention. Int Heart J. 2007;48:1–9.CrossRefPubMed

Javaid A, Buch AN, Satler LF, Kent KM, Suddath WO, Lindsay J Jr, et al. Management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol. 2006;98:911–4.CrossRefPubMed

Hendry C, Fraser D, Eichhofer J, Mamas MA, Fath-Ordoubadi F, El-Omar M, et al. Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience. Eurointervention. 2012;8:79–86.CrossRefPubMed

Taniguchi N, Takahashi A, Mizuguchi Y, Yamada T, Hata T, Nakajima S. Successful recanalization of a left circumflex artery jailed with a polytetrafluoroethylene-covered stent after coronary perforation during stent implantation in the left main bifurcation. Cardiovasc Interv Ther. 2015;30:78–81.CrossRefPubMed

Kawai Y, Kitayama M, Akao H, Motoyama A, Tsuchiya T, Kajinami K. A case of coronary rupture and pseudoaneurysm formation after fracture of implanted paclitaxel-eluting stents. Cardiovasc Interv Ther. 2015 (Epub ahead of print).

Romaguera R, Waksman R. Covered stents for coronary perforations: is there enough evidence? Catheter Cardiovasc Interv. 2011;78:246–53 (aaaa).CrossRefPubMed

10.

Fujimoto Y, Matsudo Y, Kobayashi Y. Successful delivery of polytetrafluoroethylene-covered stent through 5 French guiding catheter. J Invasive Cardiol. 2012;24:E199–201.PubMed

11.

Cola C, Miranda F, Vaguerizo B, Fantuzzi A, Bruguera J. The GuideLiner™ catheter for stent delivery in difficult cases: tips and tricks. J Interv Cardiol. 2011;24:450–61.CrossRefPubMed

12.

De Man FH, Tandjung K, Hartmann M, van Houwelingen KG, Stoel MG, Louwerenbrug HW, et al. Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry. Eurointervention. 2012;8:336–44.CrossRefPubMed

13.

Kwan TW, Diwan R, Ratclife JA, James D, Patri R, Huang Y, et al. The utility of extension catheters in transradial percutaneous coronary intervention. J Invasive Cardiol. 2015;27:28–32.PubMed

14.

Rao U, Gorog D, Suzgula J, Kumar S, Stone C, Kukreja N. The GuideLiner “child” catheter. Eurointervention. 2010;6:277–9.CrossRefPubMed

15.

Chan PH, Alegria-Barrero E, Foin N, Paulo Lindsay AC, Viceconte N, et al. Extended use of the GuideLiner in complex coronary interventions. Eurointervention. 2015;3:325–35.CrossRef

Title: Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter
Authors: Yoshihide Fujimoto
Norimasa Tonoike
Yoshio Kobayashi
Publication date: 01-04-2017
Publisher: Springer Japan
Published in: Cardiovascular Intervention and Therapeutics / Issue 2/2017
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI: https://doi.org/10.1007/s12928-016-0378-0

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

Preliminary report on a cost-utility analysis of revascularization by percutaneous coronary intervention for ischemic heart disease

Impact of a single universal guiding catheter on door-to-balloon time in primary transradial coronary intervention for ST segment elevation myocardial infarction

Usefulness of rotational atherectomy with optical frequency domain imaging guidance for severe calcified coronary lesions after Kawasaki disease

A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy

Lesion characteristics of coronary arteries associated with a mismatch between angiographic severity of stenosis and fractional flow reserve

Successful treatment of very late drug-eluting stent thrombosis using bare-metal stent evaluated using intravascular ultrasound and optical frequency domain imaging

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page